Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Voyager Therapeutics Inc VYGR

Healthcare Biotechnology
Voyager Therapeutics, Inc. is a biotechnology company focused on advancing neurogenetic medicines. The Company’s pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of its programs are derived from its TRACER AAV capsid discovery platform, which is used to generate novel... see more

Bullboard (NDAQ:VYGR)

View:
1 2 3 4 5 6 Next
Post by whytestockson Jan 02, 2024 11:00am

Voyager Therapeutics Enters Capsid License Agreement and Str

News; $VYGR Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis to Advance Novel Gene Therapies- Collaboration with gene therapy leader Novartis aims to ...more  
48
Post by Iseneschalon Nov 19, 2021 9:04am

VYGR ..... up on early a.m NR.....

Volume is light....not "Prime TIme" Cheers !
95
Post by Iseneschalon Nov 10, 2021 9:58am

VYGR ...... What did I say yesterday?

Ya gotta buy the f'ing dips....... Cheers !
115
Post by Iseneschalon Nov 08, 2021 3:54pm

VYGR ....still here

Not leaving !  Cheers !
113
Post by Iseneschalon Nov 04, 2021 1:26pm

VYGR ..... I guess that was the unexpected ... LoL

Adding to increase my nice position  Maddapakkas ! I have the patience of a dog and dry ammo to get cheap fills   LMFAO !!!!
161
Post by Iseneschalon Nov 04, 2021 10:15am

VYGR ...... Expect the unexpected.....just sayin!

I'm thinking we 're heading to the small gap that starts at $4.15 t0 $4.25....so a break of $4.25 could prove an upward trend.   Remember ...... Big Pharma (Pfizer) is in "bed" ...more  
190
Post by Iseneschalon Nov 02, 2021 12:49pm

VYGR ...... don't worry about the man behind the curtain!

It was just Mr. Maggot trying to shake everyone out of this ....slow bleed after ER news What did you expect? Still long and not leaving .  Cheers !
53
Post by Iseneschalon Nov 01, 2021 1:11pm

VYGR ....nice to see some buying pressure

Must have been a Market Buy oda for 10 K Better than a poke in the eye with a sharp stick Expect the unexpected ; )
62
Post by AviseAnalyticson Nov 01, 2021 8:02am

4 SMALL-CAP BIOTECH STOCKS FOR YOUR INVESTMENT PORTFOLIO!

$VYGR $LPTX $OCUL $MNMD   Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated approaches ...more  
104
Post by Iseneschalon Oct 29, 2021 11:15am

VYGR .....Just added ; )

Cheap is good.  Cheers !
65
Post by Iseneschalon Oct 26, 2021 11:38am

VYGR ....Is it time to add Mr. Maggot??

TRade accordingly !  Cheers !
50
1 2 3 4 5 6 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities